NEEC Research Provides New Hope for Avoiding Corneal Transplant Rejection and Ocular Surface Tumors
Scientists reveal new target for anti-lymphangiogenesis drugs Emerging field of study yields new hope for organ transplant rejection, cancer metastasis, and lymphedema BOSTON (April 12, 2016) – After an injury to tissues, such as in organ transplantation, the body grows new lymphatic vessels in a process known as lymphangiogenesis. A new study in Nature Communications… Read More
Jay Duker, MD Earns AAO’s Life Achievement Honor Award
BOSTON, MA June 4, 2015 – New England Eye Center Director Jay S. Duker, MD has received the Life Achievement Honor Award from the American Academy of Ophthalmology (AAO). He will be featured in the 2015 annual meeting Final Program. He has previously received other honor awards from the AAO. His achievements in ophthalmology are… Read More
New Treatment Found to Reduce Vision Loss from Central Retinal Vein Occlusion
Eye Injections of corticosteroid medication may improve patients’ vision BOSTON, MA September 15, 2009– New England Eye Center is pleased to announce that Scientists have identified the first long-term, effective treatment to improve vision and reduce vision loss associated with blockage of large veins in the eye. This research was part of a multi-center, phase… Read More